Neurana Pharmaceuticals, Inc. — Form D
Neurana Pharmaceuticals, Inc. of SAN DIEGO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2017-03-10. The offering totals $3.5M, of which $1.1M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2017-03-10
- Form: D
- Accession: 0001140361-17-011596
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $3.5M
- Amount sold: $1.1M
- Remaining: $2.5M
- Investors: 3
- Date of first sale: 2013-12-30
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-282295
Issuer
- Name: Neurana Pharmaceuticals, Inc.
- CIK: 0001699458
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2013
- Address: 4370 LA JOLLA VILLAGE DRIVE, SAN DIEGO, CA, 92122
- Phone: (858) 732-0702
Officers, directors & promoters (14)
| Name | Role | Location |
|---|
| Jeffrey Raser | Director | San Diego, CA |
| Jeffrey Raser | Executive Officer | San Diego, CA |
| Joshua F Richardson | Director | San Diego, CA |
| David F Kabakoff | Director | San Diego, CA |
| Craig F Thompson | Director | San Diego, CA |
| Craig F Thompson | Executive Officer | San Diego, CA |
| Brian F Dorsey | Director | San Diego, CA |
| Randall D Kaye, M.D. | Executive Officer | San Diego, CA |
| Alex F Zisson | Director | San Diego, CA |
| Judy Caron | Executive Officer | San Diego, CA |
| Daniel F Becker | Director | San Diego, CA |
| David F Hale | Director | San Diego, CA |
| David F Hale | Executive Officer | San Diego, CA |
| KATHLEEN D SCOTT | Executive Officer | SAN DIEGO, CA |
Other filings by this issuer (3)
More